UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $71
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $62 to $71.
UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE:AHR) with a Buy and raises the price target from $62 to $71.